Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | MMP8 | P22894 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NPY1R | P25929 | 1/20 | 0.45 |
| ▸ | NPY2R | P49146 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14714703 | 0.89 | NPC1 (0.45) | ALDH1A1HSD17B10MEN1KMT2ANPC1 | |
| SCHEMBL14786664 | 0.88 | ALDH1A1 (0.55) | L3MBTL1MMP8ALDH1A1LMNAPOLB | |
| SCHEMBL4927817 | 0.84 | ALDH1A1 (0.51) | L3MBTL1MMP8ALDH1A1LMNAPOLB | |
| SCHEMBL27475763 | 0.80 | L3MBTL1 (0.60) | L3MBTL1MMP8ALDH1A1LMNAPOLB | |
| SCHEMBL11015731 | 0.78 | MEN1 (0.55) | L3MBTL1MMP8ALDH1A1LMNAPOLB | |
| SCHEMBL21258291 | 0.78 | MEN1 (0.55) | L3MBTL1MMP8ALDH1A1LMNAPOLB | |
| SCHEMBL14202766 | 0.77 | NPC1 (0.51) | L3MBTL1ALDH1A1LMNAPOLBHSD17B10 | |
| SCHEMBL25205668 | 0.77 | L3MBTL1 (0.52) | L3MBTL1MMP8ALDH1A1LMNAPOLB | |
| SCHEMBL26415297 | 0.77 | ALDH1A1 (0.52) | L3MBTL1MMP8ALDH1A1LMNAPOLB | |
| SCHEMBL21258364 | 0.76 | MEN1 (0.63) | L3MBTL1ALDH1A1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12157717-B2 | Compounds for the treatment of bovine or swine respiratory disease | INTERVET INC. (US) | 2024-12-03 | — | — | US | disclosed |
| US-11498909-B2 | Compound acting as antibiotics | KBP BIOSCIENCES CO., LTD. (CN) | 2022-11-15 | — | — | US | disclosed |
| US-20210347730-A1 | COMPOUNDS FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE | INTERVET INC. (US) | 2021-11-11 | — | — | US | disclosed |
| US-20210347730-A1 | COMPOUNDS FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE | INTERVET INC. (US) | 2021-11-11 | — | — | US | disclosed |
| EP-3810571-A1 | COMPOUNDS FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE | Intervet International B.V. (NL) | 2021-04-28 | — | — | EP | disclosed |
| US-20200392096-A1 | COMPOUND ACTING AS ANTIBIOTICS | KBP BIOSCIENCES CO., LTD. (CN) | 2020-12-17 | — | — | US | disclosed |
| US-20200392096-A1 | COMPOUND ACTING AS ANTIBIOTICS | KBP BIOSCIENCES CO., LTD. (CN) | 2020-12-17 | — | — | US | disclosed |
| EP-3750881-A1 | COMPOUND ACTING AS ANTIBIOTICS | KBP Biosciences Co., Ltd. (CN) | 2020-12-16 | — | — | EP | disclosed |
| EP-3750881-A1 | COMPOUND ACTING AS ANTIBIOTICS | KBP Biosciences Co., Ltd. (CN) | 2020-12-16 | — | — | EP | disclosed |
| WO-2020002238-A1 | COMPOUNDS FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE | INTERVET INTERNATIONAL B.V. (NL) | 2020-01-02 | — | — | WO | disclosed |
| WO-2019154412-A1 | COMPOUND ACTING AS ANTIBIOTICS | 山东亨利医药科技有限责任公司 | 2019-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210347730-A1 | COMPOUNDS FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE | PIGS, BTD, PPARD | L3MBTL1 3020/4885MMP8 1172/4885ALDH1A1 845/4885 |
| US-11498909-B2 | Compound acting as antibiotics | PEPD, NRDC, DPP4 | L3MBTL1 2656/4885MMP8 745/4885ALDH1A1 1492/4885 |
| US-20200392096-A1 | COMPOUND ACTING AS ANTIBIOTICS | PEPD, NRDC, DPP4 | L3MBTL1 2656/4885MMP8 745/4885ALDH1A1 1492/4885 |
| US-12157717-B2 | Compounds for the treatment of bovine or swine respiratory disease | PIGS, BTD, PPARD | L3MBTL1 3020/4885MMP8 1172/4885ALDH1A1 845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.